Citation

91 FR 36865

Multiple canonical documents share this first-page citation.

Advisory Committee; Science Board to the Food and Drug Administration; Renewal Thursday, June 18, 2026 91 FR 36865
SpecGx LLC; Withdrawal of Approval of Abbreviated New Drug Application for Methylphenidate Hydrochloride Extended-Release Tablets, 27 Milligrams, 36 Milligrams, and 54 Milligrams Thursday, June 18, 2026 91 FR 36865